SXI Life Sciences
6 673,38
|
-194,45
|
-2,83%
|
Analysen zu SXI Life Sciences-Werten
09.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
09.09.24 | Roche Neutral | UBS AG | |
06.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
06.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
03.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
29.08.24 | Roche Outperform | Bernstein Research | |
06.08.24 | Roche Hold | Deutsche Bank AG | |
06.08.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
01.08.24 | Roche Underweight | JP Morgan Chase & Co. | |
01.08.24 | Roche Hold | Jefferies & Company Inc. | |
26.07.24 | Roche Neutral | UBS AG | |
26.07.24 | Roche Hold | Deutsche Bank AG | |
26.07.24 | Roche Equal Weight | Barclays Capital | |
25.07.24 | Roche Kaufen | DZ BANK | |
25.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
25.07.24 | Roche Hold | Jefferies & Company Inc. | |
23.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.07.24 | Roche Hold | Deutsche Bank AG | |
19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
19.07.24 | Novartis Kaufen | DZ BANK | |
19.07.24 | Novartis Hold | Deutsche Bank AG | |
19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
19.07.24 | Novartis Buy | UBS AG | |
18.07.24 | Novartis Outperform | Bernstein Research | |
18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
17.07.24 | Roche Hold | Jefferies & Company Inc. | |
17.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
17.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
15.07.24 | Roche Sell | Goldman Sachs Group Inc. | |
15.07.24 | Roche Hold | Deutsche Bank AG | |
11.07.24 | Roche Underweight | JP Morgan Chase & Co. | |
10.07.24 | Novartis Buy | Deutsche Bank AG | |
10.07.24 | Roche Hold | Deutsche Bank AG | |
10.07.24 | Roche Neutral | UBS AG | |
09.07.24 | Roche Neutral | UBS AG | |
05.07.24 | Roche Hold | Deutsche Bank AG | |
05.07.24 | Roche Underweight | JP Morgan Chase & Co. |